Frazier closes Fund X

The Menlo Park-based investment firm has raised more than $617m for its latest life sciences fund.

  • Fund name: Frazier Life Sciences X
  • Amount raised: $617 million
  • Stage of fundraising: Final close
  • Final close date: Jan 2020
  • Predecessor fund: Frazier Life Sciences IX (419m)

Frazier Healthcare Partners has closed its Frazier Life Sciences X fund at more than $617 million. It focuses on therapeutics-focused companies developing and commercializing bio-pharmaceuticals across North America.